The estimated Net Worth of Thomas W Hofmann is at least $14.5 Milión dollars as of 10 May 2024. Mr. Hofmann owns over 617 units of West Pharmaceutical Services stock worth over $13,171,575 and over the last 17 years he sold WST stock worth over $1,041,013. In addition, he makes $328,691 as Independent Director at West Pharmaceutical Services.
Sign up
Mr. Hofmann WST stock SEC Form 4 insiders trading
Thomas has made over 5 trades of the West Pharmaceutical Services stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 617 units of WST stock worth $225,773 on 10 May 2024.
The largest trade he's ever made was exercising 14,684 units of West Pharmaceutical Services stock on 21 March 2014 worth over $4,439,707. On average, Thomas trades about 816 units every 137 days since 2007. As of 10 May 2024 he still owns at least 43,564 units of West Pharmaceutical Services stock.
You can see the complete history of Mr. Hofmann stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Thomas Hofmann biography
Thomas W. Hofmann serves as Independent Director of the Company. Mr. Hofmann retired from Sunoco, Inc.—a diversified energy company—in 2008, where he was Senior Vice President and CFO from January 2002 to December 2008. In that role, he was responsible for managing the accounting, auditing, investor relations and strategic planning, tax and treasury functions of the organization. He also chaired the Company's Capital Management Committee and served as the management liaison to the Audit Committee. Mr. Hofmann served Sunoco in various other senior management roles since joining in 1977. Mr. Hofmann serves on the boards of Fox Chase Cancer Center and Temple University Health System. He also serves on the President's Leadership Council of the University of Delaware and is a member of the advisory board for Drexel University's Center for Corporate Governance.
What is the salary of Thomas Hofmann?
As the Independent Director of West Pharmaceutical Services, the total compensation of Thomas Hofmann at West Pharmaceutical Services is $328,691. There are 12 executives at West Pharmaceutical Services getting paid more, with Eric Green having the highest compensation of $6,533,690.
How old is Thomas Hofmann?
Thomas Hofmann is 68, he's been the Independent Director of West Pharmaceutical Services since 2007. There are 2 older and 24 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.
What's Thomas Hofmann's mailing address?
Thomas's mailing address filed with the SEC is 530 HERMAN O. WEST DRIVE, , EXTON, PA, 19341.
Insiders trading at West Pharmaceutical Services
Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci a Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.
What does West Pharmaceutical Services do?
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
What does West Pharmaceutical Services's logo look like?
Complete history of Mr. Hofmann stock trades at West Pharmaceutical Services
West Pharmaceutical Services executives and stock owners
West Pharmaceutical Services executives and other stock owners filed with the SEC include:
-
Eric Green,
President, Chief Executive Officer, Director -
Eric M. Green,
Pres, CEO & Director -
Bernard Birkett,
Chief Financial Officer, Senior Vice President -
George Miller,
Senior Vice President, General Counsel, Corporate Secretary -
Bernard J. Birkett,
Sr. VP & CFO -
Silji Abraham,
Senior Vice President and Chief Digital and Transformation Officer -
David Montecalvo,
Senior Vice President, Chief Operating and Supply Chain Officer -
Annette Favorite,
Chief Human Resource Officer, Senior Vice President -
David A. Montecalvo,
Sr. VP and Chief Operations & Supply Chain Officer -
Silji Abraham,
Sr. VP & Chief Technology Officer -
Patrick Zenner,
Independent Chairman of the Board -
Douglas Michels,
Independent Director -
Thomas Hofmann,
Independent Director -
Paula Johnson,
Independent Director -
William Feehery,
Independent Director -
Mark Buthman,
Independent Director -
Myla Lai-Goldman,
Independent Director -
Paolo Pucci,
Independent Director -
Deborah Keller Tanner,
Independent Director -
Chad Winters,
Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller -
Robert Friel,
Independent Director -
Cindy Reiss-Clark,
Senior Vice President of Global Market Units and Commercial Solutions -
Quintin Lai,
Vice President - Corporate Development, Strategy and Investor Relations -
Eric Resnick,
Chief Technology Officer, Vice President -
Richard D. Luzzi,
Sr. VP of HR -
Annette F. Favorite,
Chief HR Officer & Sr. VP -
Michele Polinsky,
VP of Global Communications -
Kimberly Banks MacKay,
Sr. VP, Gen. Counsel & Company Sec. -
Dr. Quintin J. Lai C.F.A., Ph.D.,
VP of Strategy & Investor Relations -
Daniel Malone,
Vice President & Controller -
William J Federici,
VP & CFO -
John H Weiland,
Director -
Karen Flynn,
President, America's Region -
Heino Lennartz,
President Europe -
Anthony Welters,
Director -
Warwick Bedwell,
VP Pharma Pkgs Systems Asia Pa -
John E Paproski,
Vice President-Innovations -
Christopher G Ryan,
President, PPS, Americas -
Rachael M Bushey,
VP, Deputy Gen Coun & Corp Sec -
Jeffrey C Hunt,
VP Pharma Pckg Systems -
John R Gailey,
VP, Gen. Counsel & Sec. -
Richard D Luzzi,
VP, Human Resourses -
L Robert Johnson,
Director -
Michael A Anderson,
Vice President & Treasurer -
Donald E Jr Morel,
Chairman of the Board & CEO -
Robert C Young,
Director -
Donald A Mc Millan,
President Pharma Systems NA -
Steven A Ellers,
Pres., Pharma. Systems Div. -
Geoffrey F Worden,
Director -
John P Neafsey,
Director -
Joseph E Abbott,
Corporate Controller -
Dijk Ronald Van,
President Asia Pacific -
Robert S Hargesheimer,
President-The Tech Group -
Fabio De Sampaio Doria Filho,
Pres., Europe & Asia Pacific -
Matthew T Mullarkey,
Chief Operating Officer -
Robert J Keating,
Pres., Europe & Asia Pacific -
Jenne K Britell,
Director -
Herbert L Hugill,
Pres. of the Americas, Pharma. -
Linda R Altemus,
VP & Chief Compliance Officer -
Molly Joseph,
Director -
Deborah L Keller,
Director -
Stephen H Lockhart,
Director -
Charles Witherspoon,
VP & Treasurer -
Kimberly Banks Mac Kay,
SVP, GC & Corporate Secretary